Stay updated with breaking news from Ed Arce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Akebia Therapeutics (AKBA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ed Arce...
Goldman Sachs increased the price target for Constellation Brands, Inc. (NYSE: STZ) from $275 to $305. Goldman Sachs analyst Bonnie Herzog maintained a Buy rating. Constellation shares fell 0.8% to $254.00 in pre-market trading.
In a report released today, Ed Arce from H.C. Wainwright maintained a Hold rating on Axcella Health (AXLA – Research Report). The company&...
Operator: Good day and welcome to Akebia's Second Quarter 2023 Financial Results Call. At this time, all participants are in a listen-only mode.
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on CVS Health (CVS – Research Report) and Iterum...